These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38043419)

  • 1. Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors.
    Chen N; Yu Y; Shen W; Xu X; Fan Y
    Clin Nutr; 2024 Jan; 43(1):142-153. PubMed ID: 38043419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
    Hou S; Song D; Hao R; Li L; Zhang Y; Zhu J
    Front Immunol; 2024; 15():1382417. PubMed ID: 38966640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic nutritional index predicts the prognosis of patients with advanced esophageal cancer treated with immune checkpoint inhibitors: a retrospective cohort study.
    Wu M; Zhu Y; Chen X; Wang X; Lin X; Yan X; Mo P; Ye Y; Zeng Y; Yang Y; Fu Z
    J Gastrointest Oncol; 2023 Feb; 14(1):54-63. PubMed ID: 36915449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor.
    Deng G; Zhu D; Du Z; Xue Y; Song H; Li Y
    Cancer Med; 2024 Mar; 13(6):e7110. PubMed ID: 38506237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study.
    Zheng F; Meng Q; Zhang L; Chen J; Zhao L; Zhou Z; Liu Y
    World J Surg Oncol; 2023 Jul; 21(1):198. PubMed ID: 37420219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung Cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB.
    Chen J; Wei S; Zhao T; Zhang X; Wang Y; Zhang X
    Dis Markers; 2022; 2022():7137357. PubMed ID: 35945957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional assessment and prognosis of oral cancer patients: a large-scale prospective study.
    Bao X; Liu F; Lin J; Chen Q; Chen L; Chen F; Wang J; Qiu Y; Shi B; Pan L; Lin L; He B
    BMC Cancer; 2020 Feb; 20(1):146. PubMed ID: 32087695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis.
    Tang W; Li C; Huang D; Zhou S; Zheng H; Wang Q; Zhang X; Fu J
    Cancer Biol Ther; 2024 Dec; 25(1):2358551. PubMed ID: 38813753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
    Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M
    Front Oncol; 2023; 13():1041140. PubMed ID: 37007079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of nutritional indicators with regard to the survival outcomes in patients with metastatic esophageal squamous cell carcinoma treated with camrelizumab.
    Liu J; Hu G; Zhai C; Wang J; Xu W; Xie J; Zhu W; Jiang P; Liu D
    Oncol Lett; 2023 May; 25(5):198. PubMed ID: 37113404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
    Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
    Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
    Miyamoto N; Takenaka Y; Sudo T; Eguchi H; Tanaka H; Fukusumi T; Takemoto N; Suzuki M; Inohara H
    Acta Otolaryngol; 2023 Oct; 143(10):925-930. PubMed ID: 38059478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of prognostic nutritional index in advanced cancer receiving PD-1/L1 inhibitors: A meta-analysis.
    Li P; Lai Y; Tian L; Zhou Q
    Cancer Med; 2022 Aug; 11(16):3048-3056. PubMed ID: 35297197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
    Nishihara-Kato F; Imai H; Tsuda T; Wasamoto S; Nagai Y; Kishikawa T; Miura Y; Ono A; Yamada Y; Masubuchi K; Osaki T; Nakagawa J; Umeda Y; Minemura H; Kozu Y; Taniguchi H; Ohta H; Kaira K; Kagamu H
    Oncology; 2024; 102(1):30-42. PubMed ID: 37598676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes.
    Chen L; Sun H; Zhao R; Huang R; Pan H; Zuo Y; Zhang L; Xue Y; Song H; Li X
    Front Pharmacol; 2022; 13():836958. PubMed ID: 35308215
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of esophageal cancer immune prognostic index in advanced esophageal squamous cell carcinoma patients with anti-programmed cell death-1 therapy.
    Lu J; Du L; Lei X; Zhang Z
    Cancer Med; 2023 May; 12(10):11334-11343. PubMed ID: 36951584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors.
    Zhang L; Ma W; Qiu Z; Kuang T; Wang K; Hu B; Wang W
    Front Immunol; 2023; 14():1219929. PubMed ID: 37545502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of inflammation and nutritional index in immunotherapy for stage IV non-small cell lung cancer and model construction.
    Lei W; Wang W; Qin S; Yao W
    Sci Rep; 2024 Jul; 14(1):17511. PubMed ID: 39080372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.